@article{ajmcr20219511,
author={{EL-Sawalhy, Eman and Al-Sudani, Najlaa and Hnayni, Wehbi and Patel, Shahina},
title={Immunoglobulin D Multiple Myeloma, a More Aggressive Subtype},
journal={American Journal of Medical Case Reports},
volume={9},
number={5},
pages={301--304},
year={2021},
url={http://pubs.sciepub.com/ajmcr/9/5/11},
issn={2374-216X},
abstract={Immunoglobulin D (IgD) multiple Myeloma (MM) is a very rare subtype of myeloma. It accounts for only 1-2% of all MM patients. It is associated with a rapidly progressive disease and poorer outcomes compared with other MM subtypes. In this case report, we present a case of a sixty-year-old man who presented to our hospital with fatigue, anemia, thrombocytopenia, and acute renal failure. His bone marrow biopsy during admission showed 75.9% of plasma cells with significant light chain burden. He was also found to have severe immunoglobulin deficiency along with a lambda to kappa ratio was <0.01. The diagnosis of IgD MM was established, and he was started on CyBorD (Bortezomib, cyclophosphamide, and dexamethasone). Our patient also required hemodialysis for his kidney failure.},
doi={10.12691/ajmcr-9-5-11}
publisher={Science and Education Publishing}
}